Assessment of bile activity of multicomponent plant extract «PENTAFIT»


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

In the structure of morbidity and mortality of the population, liver lesions occupy a leading place due to an increase in the number of uncontrolled large-scale use of drugs, pollution of the environment with chemical compounds, alcoholic intoxications. Promising for the development of pharmacological correction methods for these conditions are multicomponent agents of plant origin, characterized by the breadth of therapeutic action, low toxicity and associated long-term use without the risk of developing side reactions. The advantage of multicomponent drugs is the mutual enhancement of the beneficial pharmacological properties of each incoming ingredient, the correspondence of the multivalence of the pathogenesis of the disease, the effect on the patient's body as a whole. The article presents the results of studying the bile activity of the multicomponent plant extract, under the conditional name «Pentafit»obtained from the following types of plant raw materials: of the roots and rhizomes of Inula helenium L. - 250 g, the herb of Centaurium ery-thraea Rafn. -150 g, theflowers of Tanacetum vulgare L. -100 g, thefruits of Rosa sp. - 275 g, the fruits of Crataegus sp. 225 g under carbon tetrachloride hepatitis model conditions. It was found that course administration per os «Pentafit» at a dose of 300 mg/kg to white nonlinear rats with carbon tetrachloride liver damage increases simultaneously the bile and bile function of the liver in animals. The bile effect of the extract in toxic liver damage is due to the presence in it of a complex of biologically active substances and, above all, phenolic compounds. The obtained research results argue the feasibility of using a multicomponent plant extract «Pentafit» containing biologically active substances of phenolic nature, in the complex treatment and prevention of liver diseases.

全文:

受限制的访问

作者简介

E. Ferubko

All-Russian Scientific Research Institute of Medicinal and Aromatic Plants

Email: eferubko@yandex.ru
Ph.D. (Med.), Head of Department of Experimental Pharmacology Moscow, Russia

S. Nikolaev

General and Experimental Institute of Biology, Siberian branch of RAS

Email: smnikolaev@mail.ru
Dr.Sc. (Med.), Professor, Chief Research Scientist, Laboratory of Experimental Pharmacology Ulan-Ude, Russia

T. Dargaeva

All-Russian Scientific Research Institute of Medicinal and Aromatic Plants

Email: vilarnii@mail.ru
Dr.Sc. (Pharm.), Professor, Chief Research Scientist, Department of Chemistry of Natural Compounds Moscow, Russia

参考

  1. Ивашкин В.Т. Гастроэнтерология: национальное руководство. М.: ГЭОТАР-Медиа, 2008; 704 с.
  2. Николаев С.М. Фитофармакотерапия и фитофармакопрофилактика заболеваний. Улан-Удэ: Изд-во БГУ, 2012; 286 с.
  3. Соколов С.Я. Фитотерапия и фитофармакология. Руководство для врачей. М.: МИА, 2000; 976 с.
  4. Лубсандоржиева П.-Н.Б. Разработка и стандартизация фитосредств для лечения и профилактики заболеваний органов пищеварения. Улан-Удэ: Изд-во БНЦ СО РАН, 2016; 280 с.
  5. Патент № 2689379 Российской Федерации. Способ получения средства, обладающего антигепатотоксической активностью / Ферубко Е.В., Николаев С.М., Даргаева Т.Д. № 2019106135/19; заявл. 05.03.2019; опубл. 28.05.2019. Бюл. № 16.
  6. Руководство по проведению доклинических исследований лекарственных средств. Часть первая. М.: Гриф и К, 2012; 944 с.
  7. Боровиков В.П. Популярное введение в современный анализ данных в системе STAHSTICA. М.: Горячая линия. Телеком, 2014; 288 с.
  8. Буеверов А.О. Лекарственные поражения печени. Российский медицинский журнал. 2012; 3: 107-110.
  9. Корсун В.Ф., Николаев С.М., Огренич М.А., Корсун Е.В., Бартанова Е.А., Султанбеков Б.А. Лекарственные растения и болезни печени. М.: Издательство Мэйлер, 2014; 320 с.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russkiy Vrach Publishing House, 2021
##common.cookie##